Late dual endothelin receptor blockade with bosentan restores impaired cerebrovascular function in diabetes

Life sciences

Volumn 118, Issue 2, 2014, Pages 263-267

  Abdelsaid, Mohammed ^a   Ma, Handong ^a   Coucha, Maha ^a   Ergul, Adviye ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Basilar artery; Endothelial function; Endothelin; Middle cerebral artery; Myogenic tone

Indexed keywords

BOSENTAN; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; METFORMIN; SULFONAMIDE;

ANIMAL; BRAIN CIRCULATION; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; IN VITRO STUDY; METABOLISM; METABOLOME; MIDDLE CEREBRAL ARTERY; MUSCLE DEVELOPMENT; PATHOPHYSIOLOGY; VASOCONSTRICTION; VASODILATATION; WISTAR RAT;

ANIMALS; CEREBROVASCULAR CIRCULATION; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIN B RECEPTOR ANTAGONISTS; IN VITRO TECHNIQUES; METABOLOME; METFORMIN; MIDDLE CEREBRAL ARTERY; MUSCLE DEVELOPMENT; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; SULFONAMIDES; VASOCONSTRICTION; VASODILATION;

EID: 85027953402     PISSN: None     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2013.12.231     Document Type: Article

References (0)